Dollar cost averaging (DCA) in IKT means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More IKT Analysis
IKT DCA Calculator
Dollar Cost Averaging — Inhibikase Therapeutics, Inc.
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return-40.9%
Final Value$25.4K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return-49.2%
Final Value$21.6K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return-57.5%
Final Value$18.3K
Worst possible — still beats not investing
Best vs Worst gap16.6 pp
Your timing vs best-8.4%
Your timing vs worst+8.2%
If You Keep Investing…
Based on this stock's historical CAGR of -11.7%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$18K~1.0x your moneyfrom $18K invested
5 Years$30K~1.0x your moneyfrom $30K invested
10 Years$60K~1.0x your moneyfrom $60K invested
20 Years$120K~1.0x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.0x your money
5 Years~1.0x your money
10 Years~1.0x your money
20 Years~1.0x your money
$100/mo
$4K+$0 est. gain
$6K+$0 est. gain
$12K+$0 est. gain
$24K+$0 est. gain
$250/mo
$9K+$0 est. gain
$15K+$0 est. gain
$30K+$0 est. gain
$60K+$0 est. gain
$500/mo
$18K+$0 est. gain
$30K+$0 est. gain
$60K+$0 est. gain
$120K+$0 est. gain
$1,000/mo
$36K+$0 est. gain
$60K+$0 est. gain
$120K+$0 est. gain
$240K+$0 est. gain
* Projection assumes historical CAGR of -11.7% continues. Actual returns will vary.
Your DCA Results by Date
66 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Dec 23, 2020
$59.40
$10,000
$10,000
+0.00%
$0
Jan 25, 2021
$40.20
$10,500
$7,268
-30.78%
$-3,232
Feb 23, 2021
$42.00
$11,000
$8,093
-26.43%
$-2,907
Mar 23, 2021
$33.96
$11,500
$7,044
-38.75%
$-4,456
Apr 22, 2021
$35.34
$12,000
$7,830
-34.75%
$-4,170
May 24, 2021
$30.53
$12,500
$7,264
-41.89%
$-5,236
Jun 22, 2021
$17.22
$13,000
$4,597
-64.64%
$-8,403
Jul 22, 2021
$14.88
$13,500
$4,473
-66.87%
$-9,027
Aug 23, 2021
$12.06
$14,000
$4,125
-70.54%
$-9,875
Sep 22, 2021
$12.24
$14,500
$4,687
-67.68%
$-9,813
Oct 22, 2021
$11.16
$15,000
$4,773
-68.18%
$-10,227
Nov 23, 2021
$11.10
$15,500
$5,247
-66.15%
$-10,253
Dec 23, 2021
$9.42
$16,000
$4,953
-69.04%
$-11,047
Jan 24, 2022
$7.80
$16,500
$4,601
-72.11%
$-11,899
Feb 23, 2022
$6.18
$17,000
$4,146
-75.61%
$-12,854
Mar 23, 2022
$8.58
$17,500
$6,256
-64.25%
$-11,244
Apr 22, 2022
$7.24
$18,000
$5,779
-67.90%
$-12,221
May 23, 2022
$4.56
$18,500
$4,140
-77.62%
$-14,360
Jun 22, 2022
$5.38
$19,000
$5,384
-71.66%
$-13,616
Jul 22, 2022
$5.46
$19,500
$5,964
-69.42%
$-13,536
Aug 22, 2022
$4.56
$20,000
$5,481
-72.60%
$-14,519
Sep 22, 2022
$5.18
$20,500
$6,726
-67.19%
$-13,774
Oct 24, 2022
$4.71
$21,000
$6,616
-68.50%
$-14,384
Nov 23, 2022
$4.02
$21,500
$6,147
-71.41%
$-15,353
Dec 23, 2022
$2.97
$22,000
$5,041
-77.09%
$-16,959
Page 1 of 3
Frequently Asked Questions
Common questions about DCA investing in IKT
Investing $500 per month in Inhibikase Therapeutics, Inc. (IKT) over the past 5 years would be worth approximately $22K today. That's -49.2% total return on $43K invested, with a -11.7% compound annual growth rate (CAGR).